|
Overview
|
GOVERNMENT PRESENTATIONS |
Princeton - March 2,
2004
FDA PERSPECTIVE: The Role of Diagnostics in Drug
Discovery and Pharmacogenomics
Joseph L. Hackett, Ph.D., Special Programs Director,
Office of In Vitro Diagnostic Device, Evaluation and
Safety, CDRH, Food & Drug Administration
CMS PERSPECTIVE: Medicare's Coverage
Process in the Era of Pharmacogenomics
Sharad Mansukani M.D., M.B.A., Medical Officer/Special
Assistant, Centers for Medicare & Medicaid Services,
Department of Health & Human Services
Boston - April 23, 2003
FDA PERSPECTIVE: Future Regulation of Pharmacogenomics -
A Guidance for the Industry
David Feigal, M.D., Director, CDRH, Food & Drug
Administration
CMS PERSPECTIVE: Medicare's
Coverage Process in the Era of Pharmacogenomics
Sharad Mansukani M.D., M.B.A., Medical
Officer/Special Assistant, Centers for Medicare &
Medicaid Services, Department of Health & Human Services
(invited) |
|
QUESTIONS TO BE ADDRESSED |
• How is the Pharmaceutical Business
Model Changing?
• How will Pharmaceutical Companies Improve
Profitability in Fragmented Markets?
• How will Payors Reimburse Stratified Pharmaceutical
Therapeutics?
• How will the FDA Regulate Diagnostic Linked Therapies? |
|
Distinguished Speakers &
Panalists |
|
David Feigal, M.D.Director, CDRH, Food & Drug
Administration
Joseph L. Hackett, Ph.D., Special
Programs Director, Office of In Vitro Diagnostic Device,
Evaluation and Safety, CDRH,
Food & Drug
Administration
Sharad Mansukani M.D., M.B.A., Medical
Officer/Special Assistant,
Centers for Medicare & Medicaid Services, Department of
Health & Human Services
Patricia Deverka, M.D., M.S.,
Vice President, Scientific
Affairs, Medco Health
Robert A. Freeman, Ph.D.,
Executive Director, Public
Policy, AstraZeneca
Pharmaceuticals
Angus Hastie, Director, Marketing and
Business Development, Roche
Molecular Diagnostics
Dolly Judge, Senior Director, Federal Regulations,
Pfizer
Peter Lauper, Ph.D.,
Worldwide Vice President for
Health Economics, Pricing and Market Research, Johnson &
Johnson
Thomas A. Metcalfe,
Senior
Vice President, Business
Development/Operational Excellence, Roche Molecular
Diagnostics
Amrit Ray, M.D., M.B.A.
Director, Strategic,
Management Group,
Pfizer, Inc.
Cavan M. Redmond,
Executive Vice President &
General Manager, BioPharma Business Unit, Wyeth
Pharmaceuticals |
John L. Ryan, M.D., Ph.D.,
Senior Vice President, Experimental Medicine,
Wyeth Pharmaceuticals
Jeffrey S. Ross, M.D.,
Scientific Fellow Oncology
Molecular Medicine,
Millennium Pharmaceuticals, Inc.;
Chairman Department of Pathology and
Laboratory
Medicine, Albany Medical
College
Michael T. Stocum, M.S.,
Director, Business Development & Alliance
Management, Human Biomarker Centers,
GlaxoSmithKline R&D
Kim Slocum, Director,
Strategic Planning & Business Development, AstraZeneca
Pharmaceuticals
Stan Bernard, M.D., M.B.A.,
President, Bernard Associates and Senior Fellow - Health
Care Systems Department,
The Wharton School of Business
Andrew Branca, Vice
President and Senior Analyst, Cambridge Healthtech Advisors
Luis Gutierrez, General
Manager, Covance Health
Economics and Outcome Services
Sam Holtzman, Ph.D., Chief
Executive Officer, Rosa
Pharmaceuticals
David Parker, Ph.D, Vice
President, Covance Health
Economic and Outcome Services
Bo Saxberg, M.D., Ph.D.,
President, DDO Strategic
Services and former Vice President, Corporate Staff,
Advanced Communications for Johnson & Johnson |
WHO SHOULD ATTEND?
Strategic Resource Management is being produced for Vice
Presidents, Heads of Departments, Directors and Managers in the
following areas:
• strategic marketing
• licensing
• genomics
• strategic planning
• business development
• research & development
• pharmacogenomics
• business affairs
• regulatory affairs
• reimbursement and pricing
• new product planning
• diagnostics
Call for Sponsors
CHI offers a variety of conference sponsorships designed to
bring your company face to face with key executive
decision-makers, position your solutions/services and increase
revenue opportunities in a highly competitive marketplace. You
will interact with Vice Presidents, Heads of Departments and
Directors of Pharmaceutical and Biotechnology companies, who
will attend this focused executive forum.
For details, please contact:
Eric Glazer at 617- 630-1342 • email:
eglazer@healthtech.com
|
